AMERICAN INTERNATIONAL GROUP, INC. - SPECTRUM PHARMACEUTICALS INC ownership

SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 165 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 3.26 and the average weighting 0.0%.

Quarter-by-quarter ownership
AMERICAN INTERNATIONAL GROUP, INC. ownership history of SPECTRUM PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$104,000
-17.5%
80,948
-18.4%
0.00%0.0%
Q4 2021$126,000
-43.5%
99,204
-3.1%
0.00%0.0%
Q3 2021$223,000
-41.2%
102,407
+1.3%
0.00%0.0%
Q2 2021$379,000
+20.7%
101,062
+5.1%
0.00%0.0%
Q1 2021$314,000
-5.4%
96,195
-1.1%
0.00%0.0%
Q4 2020$332,000
-18.4%
97,299
-2.4%
0.00%
-50.0%
Q3 2020$407,000
+48.0%
99,710
+22.4%
0.00%
+100.0%
Q2 2020$275,000
+53.6%
81,489
+6.1%
0.00%0.0%
Q1 2020$179,000
-39.1%
76,828
-4.7%
0.00%0.0%
Q4 2019$294,000
-57.2%
80,643
-2.6%
0.00%
-66.7%
Q3 2019$687,000
-3.9%
82,814
-0.2%
0.00%0.0%
Q2 2019$715,000
-12.8%
83,005
+8.2%
0.00%0.0%
Q1 2019$820,000
+19.5%
76,733
-2.1%
0.00%0.0%
Q4 2018$686,000
-48.3%
78,343
-0.8%
0.00%
-25.0%
Q3 2018$1,326,000
-16.4%
78,939
+4.3%
0.00%
-33.3%
Q2 2018$1,586,000
+77.4%
75,651
+36.2%
0.01%
+100.0%
Q1 2018$894,000
-32.2%
55,545
-20.1%
0.00%
-25.0%
Q4 2017$1,318,000
+52.4%
69,531
+13.1%
0.00%
+33.3%
Q3 2017$865,000
+102.1%
61,452
+7.0%
0.00%
+50.0%
Q2 2017$428,000
+41.3%
57,406
+23.1%
0.00%
+100.0%
Q1 2017$303,000
+38.4%
46,648
-5.8%
0.00%0.0%
Q4 2016$219,000
-99.9%
49,509
-1.7%
0.00%0.0%
Q3 2016$235,158,000
-26.6%
50,355
+3.3%
0.00%0.0%
Q2 2016$320,379,000
+2.0%
48,764
-1.4%
0.00%0.0%
Q1 2016$314,000,000
+9.0%
49,466
+3.4%
0.00%0.0%
Q4 2015$288,000,000
+53134.8%
47,836
-47.1%
0.00%
-50.0%
Q3 2015$541,000
-99.9%
90,443
+0.9%
0.00%0.0%
Q2 2015$612,994,000
+104.4%
89,619
+81.4%
0.00%
+100.0%
Q1 2015$299,943,000
-65.4%
49,414
-60.5%
0.00%
-75.0%
Q4 2014$867,643,000
-12.2%
125,201
+3.1%
0.00%0.0%
Q3 2014$988,383,000
+1.7%
121,423
+1.5%
0.00%0.0%
Q2 2014$972,209,000
+155.2%
119,583
+146.1%
0.00%
+100.0%
Q1 2014$380,961,000
-8.8%
48,592
+3.0%
0.00%0.0%
Q4 2013$417,632,000
+11.1%
47,190
+5.4%
0.00%0.0%
Q3 2013$375,780,000
+10.8%
44,789
-1.5%
0.00%0.0%
Q2 2013$339,184,00045,4670.00%
Other shareholders
SPECTRUM PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
ALETHEA CAPITAL MANAGEMENT, LLC 787,973$615,0000.77%
CM Management, LLC 600,000$468,0000.50%
ARMISTICE CAPITAL, LLC 17,100,000$13,338,0000.23%
Sargent Investment Group, LLC 614,600$479,0000.15%
Ergoteles LLC 744,275$581,0000.02%
Sonora Investment Management Group, LLC 103,000$80,0000.01%
CAXTON ASSOCIATES LP 107,135$84,0000.01%
MCDONALD PARTNERS LLC 42,570$33,0000.01%
Pinz Capital Management, LP 15,600$12,0000.01%
D. E. Shaw & Co., Inc. 8,051,858$6,281,0000.01%
View complete list of SPECTRUM PHARMACEUTICALS INC shareholders